Home › Funds › Sarissa Capital Management LP › IRWD
Sarissa Capital Management LP position in IRWD
IRONWOOD PHARMACEUTICALS INC · Health Care
Sarissa Capital Management LP reported holding 9,188,635 shares of IRWD (IRONWOOD PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$38.7M, representing 21.75% of its reported portfolio and ranking #2 among its reported holdings. Sarissa Capital Management LP has disclosed IRWD holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Sarissa Capital Management LP's IRWD position evolved
Sarissa Capital Management LP first disclosed a stake in IRWD in Q3 2023 at 16,390,000 shares (US$157.8M). The position peaked in Q4 2023 at 16,390,000 shares, worth US$187.5M. Across 12 filings, Sarissa Capital Management LP increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 9 time(s). The most recent filing (Q2 2026) shows 9,188,635 shares valued at US$38.7M. Notable position changes include a 42% trim in Q1 2026 (shares rose 18% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 16.39M | $157.84M | New |
| Q4 2023 | 16.39M | $187.50M | Hold |
| Q1 2024 | 16.39M | $142.76M | Hold |
| Q2 2024 | 16.39M | $106.86M | Hold |
| Q3 2024 | 16.39M | $67.53M | Hold |
| Q4 2024 | 16.39M | $72.61M | Hold |
| Q1 2025 | 16.39M | $24.09M | Hold |
| Q2 2025 | 15.92M | $11.42M | Reduce |
| Q3 2025 | 15.92M | $20.85M | Hold |
| Q4 2025 | 15.92M | $53.65M | Hold |
| Q1 2026 | 9.19M | $32.25M | Reduce |
| Q2 2026 | 9.19M | $38.68M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About IRWD and 13F data
IRWD (IRONWOOD PHARMACEUTICALS INC) is a Health Care company. 24 other funds we track also report a position in IRWD — the largest reported positions include ARMISTICE CAPITAL, LLC (US$58.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding IRWD
- ARMISTICE CAPITAL, LLC 13.93M sh · $58.65M · Q2 2026
More on Sarissa Capital Management LP
FAQ
How long has Sarissa Capital Management LP held IRWD?
Sarissa Capital Management LP has disclosed IRWD holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is Sarissa Capital Management LP's current position in IRWD?
As of Q2 2026, Sarissa Capital Management LP holds 9.19M shares of IRWD (IRONWOOD PHARMACEUTICALS INC), valued at $38.68M, representing 21.75% of its reported portfolio and ranking #2.
Has Sarissa Capital Management LP been buying or selling IRWD?
In the latest 13F filing (Q2 2026), Sarissa Capital Management LP held unchanged its position in IRWD. The position peaked in Q4 2023 at 16.39M shares.
Which other funds hold IRWD?
Other major institutional holders of IRWD include ARMISTICE CAPITAL, LLC, among 24 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.